Dr. Juan P. Frias
Biography & Research Background
Juan P. Frias, MD, is a clinical investigator specializing in diabetes and metabolic disease and a principal investigator on multiple pivotal tirzepatide trials, including SURPASS-2, which compared tirzepatide with semaglutide in type 2 diabetes. He has authored numerous peer-reviewed publications on incretin-based therapies. Juan P. Frias is being referenced as one of the leading clinical investigators involved in the research of Tirzepatide. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Juan P. Frias is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Juan P. Frias is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.